ArticleJournal of medicinal chemistry2023

New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants.

Alessio Romerio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.